End Stage Renal Disease Clinical Trial
Official title:
Live Kidney Donor Study - Cross-Sectional and Historical Cohort Study
Kidney transplantation from living donors has been shown to carry many benefits over deceased donor transplantation. Because of benefits such as shorter waiting times and improved outcome for transplant recipients, living kidney donation accounts for an increasing number of kidney transplants nationwide. Most published studies about living kidney donation demonstrate that the procedure is safe, but they also emphasize concerns that long-term data on live donor outcomes are insufficient. The purpose of this study is to assess the long term outcomes and risks that may arise from living kidney donation.
Living donor transplants provide several advantages over deceased donor kidneys, including a
shorter waiting time. Living donor grafts also appear to have a lower rate of delayed graft
function and improved long-term recipient and graft survival. Most published studies of
living kidney donation have supported that the donation process is relatively safe for the
donor. However, these reports also emphasize concerns that comprehensive long-term data on
U.S. live donor outcomes are insufficient. One concern is that current data may
underestimate the true long-term morbidity and mortality of living kidney donation.
Additionally, older studies might not apply to the current donor population that includes
older and more obese individuals.
This is an observational study to look at the long term outcomes in living kidney donors.
This study also seeks to find out if living kidney donors are at higher risk for certain
conditions when compared to people of similar backgrounds who have not donated a kidney.
Medical history, completed questionnaires, and blood and urine tests will be collected from
donors and non donors. The compiled data from donors and non donors will be compared. Risks
for diseases related to the kidney, heart, and blood vessels will be examined between the
two groups. Quality of life and health insurance status will also be compared.
The study will be conducted in 2 phases. All donors who donated a kidney between 5 and 50
years ago at one of the three study transplant centers will be asked to take part in Phase
1. Phase 1 aims to collect limited medical information using a short questionnaire. Phase 2
will include Phase 1 donors who agree to further assessments and matched community control
participants. Participants in Phase 2 will be asked to complete more in-depth questionnaires
on health status and quality of life. Phase 2 also involves height, weight, and blood
pressure measurements. Blood and urine will be collected for this study if the participant
does not have the necessary tests within 3 years of study participation.
Seven thousand-eight hundred-sixty four (7864) previous kidney donors and about two
thousand-five hundred (2500) control subjects will be asked to take part in this study.
Participants will be recruited for this study over a 2.5.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04076488 -
Feasibility of an Interactive Tablet-based Exercise Program for People With Chronical Diseases
|
N/A | |
Completed |
NCT03289650 -
Extended Release Tacrolimus vs. Twice-Daily Tacrolimus
|
Phase 3 | |
Completed |
NCT04042324 -
A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients
|
Phase 1/Phase 2 | |
Completed |
NCT01242904 -
Use of a Bimodal Solution for Peritoneal Dialysis
|
Phase 2 | |
Active, not recruiting |
NCT03183245 -
Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis
|
Phase 3 | |
Completed |
NCT03257410 -
Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients
|
N/A | |
Completed |
NCT03627299 -
Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors
|
Phase 4 | |
Recruiting |
NCT05917795 -
Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates
|
N/A | |
Terminated |
NCT03539861 -
Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients
|
N/A | |
Withdrawn |
NCT02130817 -
Belatacept in Kidney Transplantation of Moderately Sensitized Patients
|
Phase 4 | |
Completed |
NCT05540457 -
Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis)
|
N/A | |
Not yet recruiting |
NCT04900610 -
The Effect of Vitamin K2 Supplementation on Arterial Stifness and Cardiovascular Events in PEritonial DIAlysis
|
N/A | |
Recruiting |
NCT02176434 -
Pilot Feasibility Study of Combined Kidney and Hematopoietic Stem Cell Transplantation to Cure End-stage Renal Disease
|
N/A | |
Active, not recruiting |
NCT02581449 -
Effect of Omega-3 Fatty Acids on Oxidative Stress and Dyslipidemia in Pediatric Patients Undergoing Hemodialysis
|
Phase 2 | |
Completed |
NCT02830490 -
Reliability of Functional Measures in Hemodialysis Patient.
|
N/A | |
Completed |
NCT02832466 -
Quantifying the Deterioration of Physical Function in Renal Patients
|
N/A | |
Completed |
NCT02215655 -
Increasing Autonomous Motivation in ESRD to Enhance Phosphate Binder Adherence
|
N/A | |
Completed |
NCT02832440 -
Comparison of Two Exercise Programmes in Patients Undergoing Hemodialysis
|
N/A | |
Completed |
NCT02134314 -
C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI
|
Phase 1/Phase 2 | |
Recruiting |
NCT01912001 -
Virtual Ward for Home Dialysis
|
N/A |